Assessing AThrough Radiofrequency Transseptal Puncture System for Left Atrial Access

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 177 participants.

Also called NCT06386458

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 177 participants (enrolled count) (from the registry)
Sponsor
Hangzhou NOYA MedTech Co. Ltm. (from the registry)
Registry
  • NCT NCT06386458
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06386458. Randomized; no masking; primary purpose treatment. Start 2022-07-08 (actual); primary completion 2023-05-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessing AThrough Radiofrequency Transseptal Puncture System for Left Atrial Access
Condition
Heart Diseases
Intervention (Device)
AThrough radiofrequency transseptal puncture system
Intervention (Device)
Traditional mechanical transseptal puncture needle
Lead sponsor
Hangzhou NOYA MedTech Co. Ltm. (class: industry)

Record details

Record id
cardio:ct-nct06386458
Content hash
1c572a2d9db243896f897c06b3cb86c099bf92961015d50dde06622208ca736b